Trial
NCT04773392
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Southern California
Collaborators
Veloxis Pharmaceuticals
Condition
Kidney Transplantation
Intervention
Twice-daily Tacrolimus
Why stopped
Research contract expired
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-10